Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2019

TCTMD News Team

December 30, 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News VEITH 2019

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

Todd Neale

November 25, 2019

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Conference News VIVA 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

L.A. McKeown

November 14, 2019

News Conference News VIVA 2019

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

L.A. McKeown

November 13, 2019

News Conference News VIVA 2019

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

L.A. McKeown

November 08, 2019

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Daily News

FDA: New Concerns Surface With Endologix Grafts for AAA

L.A. McKeown

October 28, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

Todd Neale

October 07, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome

Presenter: Piotr Buszman

September 27, 2019

Advertisement

Year in Review: Physicians Pick the Biggest News of 2019

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

Two Small Series Support Role for Cerebral Protection in TAVR

Future Pulmonary Embolism Interventions: Wild West or Working Together?

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

FDA: New Concerns Surface With Endologix Grafts for AAA

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Interventional Options and Future Directions for Acute PE: New AHA Statement

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content